News
5h
Total Pro Sports on MSNREPORT: All Signs Now Point To Bradley Beal Landing With Surprise Western Conference Team If Buyout HappensA report from NBC Sports points strongly toward the Clippers as the likely destination for Bradley Beal if the buyout is ...
Report – Inter Milan & Argentina Prodigy On The Verge Of Joining Genoa On Loan Without Buyout Option
Inter Milan starlet Valentin Carboni is reportedly on the cusp of joining Genoa on a season-long loan without an option to ...
The proposed sale of an Atlanta-area bank to South Carolina's First Community was prematurely announced July 8, sending ...
To officially sign Myles Turner, the Bucks needed to create some cap space. They did that by waiving nine-time All-Star point ...
As Bungie prepares Destiny 2's new Edge of Fate expansion for its imminent launch, community lead dmg04 reflects on the state ...
Verona Pharma VRNA has signed a definitive agreement with pharma bigwig Merck MRK. Per the terms, the pharma giant will acquire all outstanding shares of VRNA for $107 per American depositary share ...
On the season finale of the 32 Thoughts Podcast, Elliotte Friedman had some interesting tidbits about the Edmonton Oilers.
The NBA buyout market is expected to be active this offseason. So who are the best buyout candidates, and where might they ...
Breaking down possible landing spots for Bradley Beal if he hits free agency following a buyout from the Suns.
23h
Yardbarker on MSNFour teams interested in Suns' Bradley Beal after contract buyoutWith a contract buyout agreement between the Phoenix Suns and Bradley Beal’s $110 million salary to be completed in the coming days, teams are already lining up to sign the three-time All-Star.
The Times of India on MSN19h
Bradley Beal set to exit Phoenix Suns as buyout talks escalate, Los Angeles Clippers lead raceBut now, things may change again. On July 8, a report from ClutchPoints suggested that a buyout agreement is being worked out ...
Merck & Co. Inc. is acquiring Verona Pharma PLC in a $10 billion deal that will expand the pharmaceutical giant's portfolio of chronic obstructive pulmonary disease treatments with Verona Pharma's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results